HIS
VIR icon

Harvest Investment Services’s Vir Biotechnology VIR Stock Holding History

Harvest Investment Services’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,285
Closed -$391K – 329
2021
Q2 		$391K Sell
8,285
-752
-8% -$34.2K 0.16% 170
2021
Q1 		$463K Sell
9,037
-13,432
-60% -$724K 0.21% 134
2020
Q4 		$601K Buy
22,469
+1,840
+9% +$59.8K 0.31% 89
2020
Q3 		$708K Buy
20,629
+7,177
+53% +$309K 0.41% 63
2020
Q2 		$551K Buy
13,452
+127
+1% +$4.26K 0.33% 73
2020
Q1 		$456K Buy
+13,325
New +$358K 0.61% 48

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harvest Investment Services's VIR Position: Q3 2021 in Review

Harvest Investment Services sold out of Vir Biotechnology (VIR) in Q3 2021, closing a stake of 8,285 shares — an estimated $391K sold.

Harvest Investment Services first reported a position in VIR in Q1 2020 and held it in 6 quarters. The position peaked at $708K in Q3 2020. 175 funds tracked by Wall St. Rank hold VIR as of Q3 2021.

  • Harvest Investment Services reported no remaining Vir Biotechnology position as of Q3 2021 after selling out during the quarter.
  • Harvest Investment Services sold 8,285 Vir Biotechnology shares in Q3 2021, an estimated $391K.
  • Harvest Investment Services first reported a position in Vir Biotechnology in Q1 2020 and held it in 6 quarters.
  • Harvest Investment Services's Vir Biotechnology position peaked at $708K in Q3 2020.
  • 175 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2021.

Based on Harvest Investment Services's 13F filing for Q3 2021, filed 29 Oct 2021.